Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1977-06-27
1978-11-07
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260112R, 424 12, 23230B, G01N 3316, A61K 4300
Patent
active
041247000
ABSTRACT:
An immunoassay for the polypeptide thymic hormone thymopoietin is described. Determination of thymopoietin levels in biological fluids provides a useful diagnostic test for myasthenia gravis (elevated levels), immune deficiency diseases (reduced levels), (immunologically mediated diseases such as rheumatoid arthritis, systemic lupus erythematosus and allergy (reduced levels), cancer (reduced levels), malnutrition (reduced levels) and infections (reduced levels). The present assay is also useful as a monitor of the effectiveness of therapy in each of the aforementioned types of disease states.
REFERENCES:
patent: 4055633 (1977-10-01), Goldstein
Nucker Christine M.
Padgett Benjamin R.
Sloan Kettering Institute for Cancer Research
LandOfFree
Immunoassay for thymopoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoassay for thymopoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoassay for thymopoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2233990